Literature DB >> 19159079

Can cetuximab affect paraneoplastic myopathy?

Eleni Galani1, Anastasios Bonakis, Christos Christodoulou, George Klouvas, Angeliki Drougou, Drougou Angeliki, Dimostenis Skarlos.   

Abstract

Cetuximab given concurrently with chemotherapy has shown survival benefit for patients with metastatic colon cancer. We report a case of a patient with metastatic colon cancer who developed paraneoplastic necrotizing myopathy that possibly responded to cetuximab despite lack of improvement of the underlying cancer.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19159079     DOI： 10.1007/s11060-009-9795-6

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


  6 in total

1.  Epidermal growth factor induces vasoconstriction through the phosphatidylinositol 3-kinase-mediated mitogen-activated protein kinase pathway in hypertensive rats.

Authors:  Junghwan Kim; Chang-Kwon Lee; Hyo-Jun Park; Hyo Jin Kim; Hyun Ha So; Keun Sang Lee; Hwan Myung Lee; Hui Yul Roh; Wahn Soo Choi; Tae Kyu Park; Bokyung Kim
Journal:  J Pharmacol Sci       Date:  2006-06-10       Impact factor: 3.337

2.  Epidermal growth factor: a potent vasoconstrictor in experimental hypertension.

Authors:  J A Florian; S W Watts
Journal:  Am J Physiol       Date:  1999-03

Review 3.  Role of antibody-dependent cell-mediated cytotoxicity in the efficacy of therapeutic anti-cancer monoclonal antibodies.

Authors:  Alexandre Iannello; Ali Ahmad
Journal:  Cancer Metastasis Rev       Date:  2005-12       Impact factor: 9.264

4.  Paraneoplastic myopathy: response to intravenous immunoglobulin.

Authors:  J B Sampson; S M Smith; A G Smith; J R Singleton; S Chin; A Pestronk; K M Flanigan
Journal:  Neuromuscul Disord       Date:  2007-03-01       Impact factor: 4.296

Review 5.  Paraneoplastic necrotizing myopathy: clinical and pathological features.

Authors:  M I Levin; T Mozaffar; M T Al-Lozi; A Pestronk
Journal:  Neurology       Date:  1998-03       Impact factor: 9.910

6.  Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.

Authors:  David Cunningham; Yves Humblet; Salvatore Siena; David Khayat; Harry Bleiberg; Armando Santoro; Danny Bets; Matthias Mueser; Andreas Harstrick; Chris Verslype; Ian Chau; Eric Van Cutsem
Journal:  N Engl J Med       Date:  2004-07-22       Impact factor: 91.245
  6 in total
  3 in total

Review 1.  Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management.

Authors:  Pari Basharat; Lisa Christopher-Stine
Journal:  Curr Rheumatol Rep       Date:  2015-12       Impact factor: 4.592

2.  Paraneoplastic Necrotizing Autoimmune Myopathy in a Patient Undergoing Laparoscopic Pancreatoduodenectomy for Distal Cholangiocarcinoma.

Authors:  Stefan van Dijk; Anneke J van der Kooi; Eleonora Aronica; Thomas M van Gulik; Olivier R Busch; Marc G Besselink
Journal:  Case Rep Gastroenterol       Date:  2016-10-06

3.  Paraneoplastic Necrotizing Myopathy with a Mild Inflammatory Component: A Case Report and Review of the Literature.

Authors:  Susanne Wegener; Juliane Bremer; Paul Komminoth; Hans H Jung; Michael Weller
Journal:  Case Rep Oncol       Date:  2010-04-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.